The Senior Care Pharmacist
Overview
The Senior Care Pharmacist is a scientific journal, published since 2019 in English. The journal's country of origin is United States and its primary focus areas are geriatrics and pharmacy.
Details
Details
Abbr.
Sr Care Pharm
Start
2019
End
Continuing
Frequency
Ten issues yearly
p-ISSN
2639-9636
e-ISSN
2639-9644
Country
United States
Language
English
Specialties
Geriatrics
Pharmacy
Pharmacy
Recent Articles
1.
Antimisiaris D, Slattum P
Sr Care Pharm
. 2025 Feb;
40(3):109-110.
PMID: 40016633
No abstract available.
2.
Hitt E
Sr Care Pharm
. 2025 Feb;
40(3):115-122.
PMID: 40016632
Alzheimer's disease is the most common cause of dementia. Behavioral and psychological symptoms in dementia (BPSD) are neuropsychiatric signs accompanying dementia that carry a significant impact on prognosis and management....
3.
Tyler C, Armagon A, Garcia I, Eaton A
Sr Care Pharm
. 2025 Feb;
40(3):135-144.
PMID: 40016631
Lupus treatment recently saw the approval of new drugs after a 12-year gap since the last approval of belimumab (Benlysta) in 2011. This article reviews these newly FDA-approved agents, which...
4.
Zarowitz B, Brandt N, Cooke C, Worz C
Sr Care Pharm
. 2025 Feb;
40(3):111-114.
PMID: 40016630
No abstract available.
5.
Marshall L
Sr Care Pharm
. 2025 Feb;
40(3):123-134.
PMID: 40016629
To review the topical therapies for adults, including older adults, with atopic dermatitis. A background on atopic dermatitis in adults, overview of treatment recommendations, and the pharmacists' role for care...
6.
7.
Tulcewicz P, Atkinson K, Koff A, Smith C
Sr Care Pharm
. 2025 Feb;
40(3):145-149.
PMID: 40016627
In recent years, aspirin use has been controversial for primary prevention of atherosclerotic cardiovascular disease (ASCVD) events. Numerous clinical trials have proven that aspirin does not improve outcomes and increases...
8.
9.
Montgomery D, Shin T, Newell B
Sr Care Pharm
. 2025 Feb;
40(2):64-71.
PMID: 39891326
To describe a successful pharmacist-led intervention to effectively and safely provide education and pharmacotherapy management for an older patient with uncontrolled type 2 diabetes mellitus (T2DM) who failed to remove...
10.
Jeter A, Melton B, Newell B
Sr Care Pharm
. 2025 Feb;
40(2):97-104.
PMID: 39891325
In 2022, federal law capped insulin product costs at $35 per month for Medicare prescription drug plan recipients. However, this law did not address the high costs of other antihyperglycemic...